Tavo Espinoza
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ligand Pharmaceuticals Inc (LGND) | Chief Financial Officer | $522,825 | $4,382,148 |
| 2024 | Ligand Pharmaceuticals Inc (LGND) | Chief Financial Officer | $469,550 | $3,298,556 |
| 2023 | Ligand Pharmaceuticals Inc (LGND) | Chief Financial Officer | $433,005 | $2,450,631 |
| 2022 | Ligand Pharmaceuticals Inc (LGND) | Chief Financial Officer | $330,097 | $3,272,252 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.